ArticleClinical and translational medicine2022

Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid-induced skeletal muscle atrophy.

Lin Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.